A first-in-class inhibitor of ER coregulator PELP1 targets ER+ breast cancer. Altwegg KA, Viswanadhapalli S, Mann M, Chakravarty D, et al. Cancer Res 2022 Aug 11. pii: 707658. doi: 10.1158/0008-5472.CAN-22-0698.

Read + Share

Amedeo Smart

Independent Medical Education

Altwegg KA, Viswanadhapalli S, Mann M, Chakravarty D, et al. A first-in-class inhibitor of ER coregulator PELP1 targets ER+ breast cancer. Cancer Res 2022 Aug 11. pii: 707658. doi: 10.1158/0008-5472.CAN-22-0698.
PMID: 35950923